APA (7th ed.) Citation

YT, C., & YS, K. (2023). Comment to "Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer". Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 189, 109919. https://doi.org/10.1016/j.radonc.2023.109919

Chicago Style (17th ed.) Citation

YT, Chien, and Kao YS. "Comment to "Dosimetric Correlates of Toxicities and Quality of Life Following Two-fraction Stereotactic Ablative Radiotherapy (SABR) for Prostate Cancer"." Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 189 (2023): 109919. https://doi.org/10.1016/j.radonc.2023.109919.

MLA (9th ed.) Citation

YT, Chien, and Kao YS. "Comment to "Dosimetric Correlates of Toxicities and Quality of Life Following Two-fraction Stereotactic Ablative Radiotherapy (SABR) for Prostate Cancer"." Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 189, 2023, p. 109919, https://doi.org/10.1016/j.radonc.2023.109919.